M.E. Kelly

4.1k total citations
82 papers, 3.4k citations indexed

About

M.E. Kelly is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, M.E. Kelly has authored 82 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Cellular and Molecular Neuroscience, 23 papers in Molecular Biology and 12 papers in Cognitive Neuroscience. Recurrent topics in M.E. Kelly's work include Neurotransmitter Receptor Influence on Behavior (28 papers), Neuroscience and Neuropharmacology Research (18 papers) and Receptor Mechanisms and Signaling (13 papers). M.E. Kelly is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (28 papers), Neuroscience and Neuropharmacology Research (18 papers) and Receptor Mechanisms and Signaling (13 papers). M.E. Kelly collaborates with scholars based in United Kingdom, Ireland and United States. M.E. Kelly's co-authors include B. Costall, R.J. Naylor, A.M. Domeney, D.M. Tomkins, Robert J. Naylor, Brian J. Jones, M.B. Tyers, E.S. Onaivi, Philip Gerrard and Nicholas M. Barnes and has published in prestigious journals such as Nature, Brain Research and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

M.E. Kelly

80 papers receiving 3.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
M.E. Kelly 2.0k 1.3k 526 487 418 82 3.4k
John H. Kehne 1.9k 1.0× 903 0.7× 533 1.0× 351 0.7× 386 0.9× 68 3.2k
David T. George 1.3k 0.7× 598 0.5× 535 1.0× 355 0.7× 593 1.4× 135 4.7k
Mitsuhiko Yamada 1.7k 0.9× 1.5k 1.2× 339 0.6× 514 1.1× 260 0.6× 181 4.1k
Gail Winger 3.1k 1.6× 1.3k 1.0× 786 1.5× 271 0.6× 299 0.7× 114 4.8k
John R. Glowa 2.8k 1.4× 1.5k 1.2× 704 1.3× 596 1.2× 798 1.9× 96 4.4k
James H. Woods 2.7k 1.4× 1.5k 1.2× 644 1.2× 266 0.5× 242 0.6× 138 4.3k
David Nutt 1.3k 0.7× 758 0.6× 480 0.9× 240 0.5× 256 0.6× 72 2.5k
H.J. Little 2.8k 1.4× 1.5k 1.2× 710 1.3× 195 0.4× 510 1.2× 124 4.0k
N. Brunello 1.8k 0.9× 1.2k 1.0× 415 0.8× 329 0.7× 936 2.2× 139 4.6k
Alessandro Tagliamonte 1.5k 0.8× 700 0.6× 250 0.5× 363 0.7× 301 0.7× 52 2.8k

Countries citing papers authored by M.E. Kelly

Since Specialization
Citations

This map shows the geographic impact of M.E. Kelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.E. Kelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.E. Kelly more than expected).

Fields of papers citing papers by M.E. Kelly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.E. Kelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.E. Kelly. The network helps show where M.E. Kelly may publish in the future.

Co-authorship network of co-authors of M.E. Kelly

This figure shows the co-authorship network connecting the top 25 collaborators of M.E. Kelly. A scholar is included among the top collaborators of M.E. Kelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.E. Kelly. M.E. Kelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lydon, Sinéad, et al.. (2019). An analysis of general practitioners’ perspectives on patient safety incidents using critical incident technique interviews. Family Practice. 36(6). 736–742. 17 indexed citations
2.
Heerey, Adrienne, et al.. (2017). Point-of-care testing in primary care: needs and attitudes of Irish GPs. BJGP Open. 1(4). bjgpopen17X101229–bjgpopen17X101229. 6 indexed citations
3.
Lydon, Sinéad, et al.. (2017). A Systematic Review of Primary Care Safety Climate Survey Instruments: Their Origins, Psychometric Properties, Quality, and Usage. Journal of Patient Safety. 14(2). e9–e18. 16 indexed citations
4.
Kelly, M.E., Jon Dowell, John Newell, et al.. (2014). The fairness, predictive validity and acceptability of multiple mini interview in an internationally diverse student population- a mixed methods study. BMC Medical Education. 14(1). 267–267. 37 indexed citations
5.
Rogers, Derek C., B. Costall, A.M. Domeney, et al.. (2000). Anxiolytic profile of ropinirole in the rat, mouse and common marmoset. Psychopharmacology. 151(1). 91–97. 42 indexed citations
6.
Harder, J. A. & M.E. Kelly. (1997). The Effect of Several Putative Cognition Enhancers on a Water Maze Acquisition Deficit Produced by pCPA + Scopolamine Combination Treatment. Pharmacology Biochemistry and Behavior. 56(4). 657–661. 5 indexed citations
7.
Harder, J. A., M.E. Kelly, Christopher H.K. Cheng, & B. Costall. (1996). Combined pCPA and muscarinic antagonist treatment produces a deficit in rat water maze acquisition. Pharmacology Biochemistry and Behavior. 55(1). 61–65. 26 indexed citations
8.
Costall, B., et al.. (1994). Actions of 5-hydroxytryptophan to inhibit and disinhibit mouse behaviour in the light/dark test. European Journal of Pharmacology. 255(1-3). 39–49. 25 indexed citations
9.
Bratt, Alison M., M.E. Kelly, A.M. Domeney, Robert J. Naylor, & B. Costall. (1994). Ondansetron fails to attenuate a scopolamineinduced deficit in a Stone maze task. Neuroreport. 5(15). 1921–1924. 15 indexed citations
10.
Costall, B., et al.. (1992). Profile of action of a novel 5-hydroxytryptamine1A receptor ligand E-4424 to inhibit aversive behavior in the mouse, rat and marmoset.. Journal of Pharmacology and Experimental Therapeutics. 262(1). 90–98. 43 indexed citations
11.
Barnes, Nicholas M., et al.. (1992). Profiles of interaction of R(+)/S(-)-zacopride and anxiolytic agents in a mouse model. European Journal of Pharmacology. 218(1). 91–100. 27 indexed citations
12.
Costall, B., A.M. Domeney, Philip Gerrard, et al.. (1991). Preclinical pharmacology of ropinirole (SK&F 101468-A) a novel dopamine D2 agonist. Pharmacology Biochemistry and Behavior. 38(1). 147–154. 117 indexed citations
13.
Barnes, Nicholas M., B. Costall, M.E. Kelly, Deborah Murphy, & Robert J. Naylor. (1991). Cognitive enhancing actions of PD123177 detected in a mouse habituation paradigm. Neuroreport. 2(6). 351–353. 74 indexed citations
14.
Barnes, Janine M., Nicholas M. Barnes, B. Costall, et al.. (1990). The differential activities of R(+)- and S(−)-zacopride as 5-HT3 receptor antagonists. Pharmacology Biochemistry and Behavior. 37(4). 717–727. 50 indexed citations
15.
Barnes, Nicholas M., et al.. (1990). Cognitive enhancing actions of DuP 753 detected in a mouse habituation paradigm. Neuroreport. 1(3). 239–242. 49 indexed citations
16.
Barnes, Janine M., Nicholas M. Barnes, B. Costall, et al.. (1990). Neurochemical consequences following injection of the substance P analogue, DiMe-C7, into the rat ventral tegmental area. Pharmacology Biochemistry and Behavior. 37(4). 839–841. 18 indexed citations
17.
Kelly, M.E.. (1989). The Journal of Vocational and Technical Education: A Review of Articles Submitted and in Print.. Journal of Career and Technical Education. 5(2). 50–60.
18.
Jones, Brian J., B. Costall, A.M. Domeney, et al.. (1988). The potential anxiolytic activity of GR38032F, a 5‐HT3‐receptor antagonist. British Journal of Pharmacology. 93(4). 985–993. 282 indexed citations
19.
Kelly, M.E.. (1986). Enablers and Inhibitors to Research Productivity among High and Low Producing Vocational Education Faculty Members.. Korean Society for the Study of Vocational Education. 11(4). 63–80. 1 indexed citations
20.
Costall, B., M.E. Kelly, & Robert J. Naylor. (1984). Unilateral striatal dopamine denervation: Reduced motor inhibitory effects of dopamine antagonists revealed in models of asymmetric and circling behaviour. Naunyn-Schmiedeberg s Archives of Pharmacology. 326(1). 29–35. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John H. Kehne Breakdown of academic impact, for papers by David T. George Breakdown of academic impact, for papers by Mitsuhiko Yamada Breakdown of academic impact, for papers by Gail Winger Breakdown of academic impact, for papers by John R. Glowa Breakdown of academic impact, for papers by James H. Woods Breakdown of academic impact, for papers by David Nutt Breakdown of academic impact, for papers by H.J. Little Breakdown of academic impact, for papers by N. Brunello Breakdown of academic impact, for papers by Alessandro Tagliamonte
Rankless by CCL
2026